Literature DB >> 26408154

Bone Density Screening and Re-screening in Postmenopausal Women and Older Men.

Margaret L Gourlay1, Robert A Overman2, Kristine E Ensrud3,4.   

Abstract

Clinical practice guidelines universally recommend bone mineral density (BMD) screening to identify osteoporosis in women aged 65 years and older. Risk assessment is recommended to guide BMD screening in postmenopausal women under age 65. Insufficient data are available to inform standard ages to start and stop BMD screening in postmenopausal women. Based on longitudinal studies of incident osteoporosis and fracture in postmenopausal women, an initial BMD test should be ordered for all women aged 65, and the frequency of re-screening should be based on age and BMD T score (more frequent testing for older age and lower T score). Although clinical practice guidelines recommend BMD screening according to risk factors for fracture in postmenopausal women under age 65, no standard approach to risk assessment exists. Minimal evidence is available to guide osteoporosis screening in men, but some experts recommend initiation of BMD screening in men at age 70.

Entities:  

Keywords:  Bone density; Men; Osteoporosis; Postmenopausal women; Screening

Mesh:

Year:  2015        PMID: 26408154      PMCID: PMC4623874          DOI: 10.1007/s11914-015-0289-5

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  80 in total

1.  Severely suppressed bone turnover: a potential complication of alendronate therapy.

Authors:  Clarita V Odvina; Joseph E Zerwekh; D Sudhaker Rao; Naim Maalouf; Frank A Gottschalk; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

2.  Hip fracture in women without osteoporosis.

Authors:  Stacey A Wainwright; Lynn M Marshall; Kristine E Ensrud; Jane A Cauley; Dennis M Black; Teresa A Hillier; Marc C Hochberg; Molly T Vogt; Eric S Orwoll
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

3.  Survival after hip fracture: short- and long-term excess mortality according to age and gender.

Authors:  L Forsén; A J Sogaard; H E Meyer; T Edna; B Kopjar
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

4.  Predictive value of BMD for hip and other fractures.

Authors:  Olof Johnell; John A Kanis; Anders Oden; Helena Johansson; Chris De Laet; Pierre Delmas; John A Eisman; Seiko Fujiwara; Heikki Kroger; Dan Mellstrom; Pierre J Meunier; L Joseph Melton; Terry O'Neill; Huibert Pols; Jonathan Reeve; Alan Silman; Alan Tenenhouse
Journal:  J Bone Miner Res       Date:  2005-03-07       Impact factor: 6.741

5.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

6.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

7.  Hip fracture prediction in elderly men and women: validation in the Rotterdam study.

Authors:  C E De Laet; B A Van Hout; H Burger; A E Weel; A Hofman; H A Pols
Journal:  J Bone Miner Res       Date:  1998-10       Impact factor: 6.741

Review 8.  Epidemiology of osteoporotic fractures.

Authors:  Olof Johnell; John Kanis
Journal:  Osteoporos Int       Date:  2004-09-08       Impact factor: 4.507

9.  Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents.

Authors:  Claudie Berger; Lisa Langsetmo; Lawrence Joseph; David A Hanley; K Shawn Davison; Robert Josse; Nancy Kreiger; Alan Tenenhouse; David Goltzman
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

10.  Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis.

Authors:  Emily Banks; Gillian K Reeves; Valerie Beral; Angela Balkwill; Bette Liu; Andrew Roddam
Journal:  PLoS Med       Date:  2009-11-10       Impact factor: 11.069

View more
  4 in total

1.  Association of Hypertension and Lipid Profile with Osteoporosis.

Authors:  Mohammed Al-Hariri; Bander Aldhafery
Journal:  Scientifica (Cairo)       Date:  2020-07-12

2.  Potential cause affecting bone quality in Saudi Arabia: New insights.

Authors:  Mohammed T Al-Hariri; Roaa Al Goweiz; Bander Aldhafery; Majed M Alsadah; Ahmed S Alkathim; Mohsen Z AlQassab; Abdullah H AlRammadan; Mahmoud A AlElaq
Journal:  J Family Med Prim Care       Date:  2021-01-30

3.  Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.

Authors:  D Canoy; N C Harvey; D Prieto-Alhambra; C Cooper; H E Meyer; B O Åsvold; M Nazarzadeh; K Rahimi
Journal:  Osteoporos Int       Date:  2021-10-13       Impact factor: 5.071

4.  Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study.

Authors:  Keita Hirano; Daiki Kobayashi; Naoto Kohtani; Yukari Uemura; Yasuo Ohashi; Yasuhiro Komatsu; Motoko Yanagita; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2019-01-28       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.